Management of Fat Necrosis after Autologous Fat Transplantation for Breast Augmentation

Jeng Yee Lin, Ping Song, Lee Li-Qun Pu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND: Palpable lumps as sequelae of fat necrosis after fat grafting to the breast may not only cause physical or psychological symptoms to patients but also potentially complicate breast cancer screening. In this article, the authors present their experience in management of fat necrosis following fat grafting for breast augmentation. METHODS: Over a 5-year period, a total of 685 Asian women (age range, 20 to 58 years) underwent autologous fat transplantation to the breasts. The average volume of fat graft to each breast was 205 ± 45 cc. The preoperative and postoperative photographs and the breast volume were recorded. Detection of fat necrosis was based on clinical examinations and imaging studies. The mean follow-up was 208 ± 36 days. RESULTS: The mean volume increase was 135 ± 20 cc in a single breast, with a mean graft retention rate of 65 percent. Sixty-six patients (9.6 percent) were found to have fat necrosis in the form of solitary or multiple cysts, sclerotic nodules, or calcifications in either one or both breasts postoperatively. The average time before first detection of the breast lump was 108 ± 45 days. Management of fat necrosis included aspiration or excision based on the authors' treatment algorithm. The symptoms related to fat necrosis such as discomfort on palpation, pain, or possible skin reaction were significantly improved in 54 of 57 patients (94.7 percent). CONCLUSIONS: Fat necrosis following autologous fat grafting for breast augmentation can be managed successfully and its related symptoms can be relieved in 94.7 percent of patients. It can be approached safely based on a sound algorithm developed by the authors. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Original languageEnglish (US)
Pages (from-to)665e-673e
JournalPlastic and reconstructive surgery
Volume142
Issue number5
DOIs
StatePublished - Nov 1 2018

Fingerprint

Fat Necrosis
Autologous Transplantation
Breast
Fats
Transplants
Palpation
Early Detection of Cancer
Cysts
Breast Neoplasms
Psychology
Pain

ASJC Scopus subject areas

  • Surgery

Cite this

Management of Fat Necrosis after Autologous Fat Transplantation for Breast Augmentation. / Lin, Jeng Yee; Song, Ping; Pu, Lee Li-Qun.

In: Plastic and reconstructive surgery, Vol. 142, No. 5, 01.11.2018, p. 665e-673e.

Research output: Contribution to journalArticle

@article{619ef82e1db54170891c3b814ec5f3ac,
title = "Management of Fat Necrosis after Autologous Fat Transplantation for Breast Augmentation",
abstract = "BACKGROUND: Palpable lumps as sequelae of fat necrosis after fat grafting to the breast may not only cause physical or psychological symptoms to patients but also potentially complicate breast cancer screening. In this article, the authors present their experience in management of fat necrosis following fat grafting for breast augmentation. METHODS: Over a 5-year period, a total of 685 Asian women (age range, 20 to 58 years) underwent autologous fat transplantation to the breasts. The average volume of fat graft to each breast was 205 ± 45 cc. The preoperative and postoperative photographs and the breast volume were recorded. Detection of fat necrosis was based on clinical examinations and imaging studies. The mean follow-up was 208 ± 36 days. RESULTS: The mean volume increase was 135 ± 20 cc in a single breast, with a mean graft retention rate of 65 percent. Sixty-six patients (9.6 percent) were found to have fat necrosis in the form of solitary or multiple cysts, sclerotic nodules, or calcifications in either one or both breasts postoperatively. The average time before first detection of the breast lump was 108 ± 45 days. Management of fat necrosis included aspiration or excision based on the authors' treatment algorithm. The symptoms related to fat necrosis such as discomfort on palpation, pain, or possible skin reaction were significantly improved in 54 of 57 patients (94.7 percent). CONCLUSIONS: Fat necrosis following autologous fat grafting for breast augmentation can be managed successfully and its related symptoms can be relieved in 94.7 percent of patients. It can be approached safely based on a sound algorithm developed by the authors. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.",
author = "Lin, {Jeng Yee} and Ping Song and Pu, {Lee Li-Qun}",
year = "2018",
month = "11",
day = "1",
doi = "10.1097/PRS.0000000000004898",
language = "English (US)",
volume = "142",
pages = "665e--673e",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Management of Fat Necrosis after Autologous Fat Transplantation for Breast Augmentation

AU - Lin, Jeng Yee

AU - Song, Ping

AU - Pu, Lee Li-Qun

PY - 2018/11/1

Y1 - 2018/11/1

N2 - BACKGROUND: Palpable lumps as sequelae of fat necrosis after fat grafting to the breast may not only cause physical or psychological symptoms to patients but also potentially complicate breast cancer screening. In this article, the authors present their experience in management of fat necrosis following fat grafting for breast augmentation. METHODS: Over a 5-year period, a total of 685 Asian women (age range, 20 to 58 years) underwent autologous fat transplantation to the breasts. The average volume of fat graft to each breast was 205 ± 45 cc. The preoperative and postoperative photographs and the breast volume were recorded. Detection of fat necrosis was based on clinical examinations and imaging studies. The mean follow-up was 208 ± 36 days. RESULTS: The mean volume increase was 135 ± 20 cc in a single breast, with a mean graft retention rate of 65 percent. Sixty-six patients (9.6 percent) were found to have fat necrosis in the form of solitary or multiple cysts, sclerotic nodules, or calcifications in either one or both breasts postoperatively. The average time before first detection of the breast lump was 108 ± 45 days. Management of fat necrosis included aspiration or excision based on the authors' treatment algorithm. The symptoms related to fat necrosis such as discomfort on palpation, pain, or possible skin reaction were significantly improved in 54 of 57 patients (94.7 percent). CONCLUSIONS: Fat necrosis following autologous fat grafting for breast augmentation can be managed successfully and its related symptoms can be relieved in 94.7 percent of patients. It can be approached safely based on a sound algorithm developed by the authors. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

AB - BACKGROUND: Palpable lumps as sequelae of fat necrosis after fat grafting to the breast may not only cause physical or psychological symptoms to patients but also potentially complicate breast cancer screening. In this article, the authors present their experience in management of fat necrosis following fat grafting for breast augmentation. METHODS: Over a 5-year period, a total of 685 Asian women (age range, 20 to 58 years) underwent autologous fat transplantation to the breasts. The average volume of fat graft to each breast was 205 ± 45 cc. The preoperative and postoperative photographs and the breast volume were recorded. Detection of fat necrosis was based on clinical examinations and imaging studies. The mean follow-up was 208 ± 36 days. RESULTS: The mean volume increase was 135 ± 20 cc in a single breast, with a mean graft retention rate of 65 percent. Sixty-six patients (9.6 percent) were found to have fat necrosis in the form of solitary or multiple cysts, sclerotic nodules, or calcifications in either one or both breasts postoperatively. The average time before first detection of the breast lump was 108 ± 45 days. Management of fat necrosis included aspiration or excision based on the authors' treatment algorithm. The symptoms related to fat necrosis such as discomfort on palpation, pain, or possible skin reaction were significantly improved in 54 of 57 patients (94.7 percent). CONCLUSIONS: Fat necrosis following autologous fat grafting for breast augmentation can be managed successfully and its related symptoms can be relieved in 94.7 percent of patients. It can be approached safely based on a sound algorithm developed by the authors. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

UR - http://www.scopus.com/inward/record.url?scp=85062045972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062045972&partnerID=8YFLogxK

U2 - 10.1097/PRS.0000000000004898

DO - 10.1097/PRS.0000000000004898

M3 - Article

C2 - 30511971

AN - SCOPUS:85062045972

VL - 142

SP - 665e-673e

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 5

ER -